News

Under the contracts, Astellas will develop and commercialize TransVax, however Vical will take care of the co-promotion in US. Additionally, Vical will support Astellas in manufacturing, development and

The open-label, two-arm dose escalation trial intends to establish the maximum tolerated dose of BMN 673. The trial will also evaluate the pharmacodynamics, pharmacokinetics, safety and preliminary efficacy

J&J signed a definitive agreement to acquire JB Chemicals in 26 May 2011, as part of its plan to widen its presence in Russia. The acquisition includes multi-symptom

Firecrest, with its web-based solution, provides study information, training manuals for the study sites. ICON CEO Peter Gray said delivering consistent, real-time information to sites and a clear

The approval for Benlysta was granted as an additional therapy for the adult patients suffering from active autoantibody-positive systemic lupus erythematosus (SLE) with high degree of disease activity.

Life Technologies said the drug delivery technology is ready for license, as a part of a new out-licensing program. The product is expected to offer improvement and help

Brazil-based Engefiltro, which has filtration systems engineering capabilities, has presence across various industries including pharma. This expertise increases Pall’s regional capabilities in the design, construction and servicing of

Aptalis Pharma will offer Zenpep in 25,000 units of lipase for pateints with exocrine pancreatic insufficiency (EPI) caused by CF or other conditions. Aptalis Pharma president and CEO

The joint venture, which is a 50-50 partnership deal, is expected to provide active pharmaceutical ingredients (API) to various other pharmaceutical firms. With this manufacturing plant, the companies